Home » India’s Drug Regulator Proposes to Hasten Trial Approvals
India’s Drug Regulator Proposes to Hasten Trial Approvals
India’s Central Drug Standard Control Organization (CDSCO) plans to approve new rules for clinical trials in a few months that will reduce the approval time for applications, a senior official said.
The new rules — which will speed up approval time for application reviews to between 30 to 60 days — are intended to stimulate clinical research in the country, which has slowed down in recent years, Ranga Chandrashekhar, a deputy drugs controller at CDSCO, said at a Mumbai pharmaceutical conference.
Chandrashekhar said CDSCO has already received comments from stakeholders on its draft and it expects to finalize the rules in about two months.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May